The historical rank and industry rank for Achieve Life Sciences's Equity-to-Asset or its related term are showing as below:
ACHV'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.08 Med: 0.7 Max: 0.93
Current: 0.66
During the past 13 years, the highest Equity to Asset Ratio of Achieve Life Sciences was 0.93. The lowest was -0.08. And the median was 0.70.
ACHV's Equity-to-Asset is ranked worse than 50.33% of 1512
companies
in the Biotechnology industry
Industry Median: 0.67
vs ACHV: 0.66
Achieve Life Sciences Equity-to-Asset Historical Data
The historical data trend for Achieve Life Sciences's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Achieve Life Sciences's Equity-to-Asset
For the Biotechnology subindustry, Achieve Life Sciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Achieve Life Sciences's Equity-to-Asset Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Achieve Life Sciences's Equity-to-Asset falls into.
Achieve Life Sciences Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Achieve Life Sciences's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Achieve Life Sciences (NAS:ACHV) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Achieve Life Sciences Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Achieve Life Sciences's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ACHV has been successfully added to your 